Cullinan Oncology Analyst Ratings
BenzingaApr 17 11:17 ET
Cullinan Oncology Analyst Ratings
BenzingaApr 16 12:51 ET
Cullinan Oncology Analyst Ratings
BenzingaApr 15 08:10 ET
Cullinan Oncology Analyst Ratings
BenzingaMar 14 12:42 ET
Cullinan Oncology Analyst Ratings
BenzingaFeb 15 08:49 ET
JonesTrading Initiates Coverage On Cullinan Oncology With Buy Rating, Announces Price Target of $22
BenzingaOct 6, 2023 05:50 ET
Cullinan Oncology Analyst Ratings
BenzingaOct 6, 2023 05:49 ET
HC Wainwright & Co. Reiterates Buy on Cullinan Oncology, Lowers Price Target to $34
BenzingaAug 11, 2023 13:10 ET
Cullinan Oncology Analyst Ratings
BenzingaAug 11, 2023 13:09 ET
Cullinan Oncology Analyst Ratings
BenzingaAug 9, 2023 10:28 ET
Analyst Ratings for Cullinan Oncology
BenzingaJul 7, 2023 08:04 ET
HC Wainwright & Co. Reiterates Buy on Cullinan Oncology, Maintains $49 Price Target
BenzingaJul 7, 2023 06:05 ET
HC Wainwright & Co. Reiterates Buy on Cullinan Oncology, Maintains $49 Price Target
BenzingaJun 5, 2023 06:30 ET
HC Wainwright & Co. Reiterates Buy on Cullinan Oncology, Maintains $49 Price Target
BenzingaMay 26, 2023 06:12 ET
HC Wainwright Adjusts Price Target on Cullinan Oncology to $49 From $50, Maintains Buy Rating
MT NewswiresMay 12, 2023 07:12 ET
HC Wainwright & Co. Maintains Buy on Cullinan Oncology, Lowers Price Target to $49
BenzingaMay 12, 2023 06:22 ET
What 4 Analyst Ratings Have To Say About Cullinan Oncology
BenzingaMar 27, 2023 12:01 ET
HC Wainwright & Co. Reiterates Buy on Cullinan Oncology, Maintains $50 Price Target
BenzingaMar 27, 2023 09:14 ET
Cullinan Oncology Analyst Ratings
Benzinga Analyst RatingsFeb 15, 2023 04:48 ET
Morgan Stanley Adjusts Price Target on Cullinan Oncology to $19 From $27, Maintains Overweight Rating
MT NewswiresFeb 3, 2023 09:39 ET
No Data
No Data